This content is machine translated Multiple sclerosis Future prospects: focus on personalized therapy Approximately 15,000 people in Switzerland are diagnosed with multiple sclerosis. The disease is not yet curable. Still. This is because ever better knowledge of the pathophysiology of the disease is…
View Post 4 min This content is machine translated "Mild Cognitive Impairment" (MCI). Ginkgo biloba for the improvement of neurocognitive symptoms Patients with mild cognitive function impairment – mostly affecting those over 60 years of age – may benefit from symptomatic therapy based on a standardized extract of ginkgo. This is…
View Post 3 min This content is machine translated Dementia Still forgetful or already demented? Effective treatment from the beginning The first signs of dementia are often not recognized, because the changes in the brain occur gradually. Often, a depressive episode also masks the actual symptoms. However, in order to…
View Post 4 min This content is machine translated Epilepsy Modern treatment management focuses on monotherapy The range of therapies for generalized and especially focal epilepsies is constantly expanding, so that the treatment regime can now be individually adapted to the needs of those affected. However,…
View Post 3 min This content is machine translated Parkinson's disease What is still possible when seemingly nothing else works Contemporary Parkinson’s therapy is multidisciplinary and is based on the individual needs of the patient. The experts at the dgp-Congress agreed. Increasing understanding of disease progression will enable personalized treatment,…
View Post 10 min This content is machine translated Sponsored Content: 5q-associated spinal muscular atrophy (5q-SMA). Nusinersen: Central to CNS, targeted effect. The antisense oligonucleotide nusinersen was approved in 2017 as the first drug for the causal treatment of patients with 5q-associated spinal muscular atrophy (5q-SMA) [1]. The drug targets the cause…
View Post 3 min This content is machine translated Multiple sclerosis Diagnosis, differential diagnosis and treatment up to date Depending on its course, multiple sclerosis can lead to rapid losses in quality of life. Research is working at full speed to further detect the pathology of the disease and…
View Post 4 min This content is machine translated Multiple sclerosis MS therapy: updated guideline and further updates at a glance The range of disease-modifying therapies (DMTs) for MS patients has expanded steadily in recent years. This has also been incorporated into the new edition of the DGN guideline. The benefits…
View Post 6 min This content is machine translated The Parkinson therapy in the very old Age does not make it better Although old age is not typical for PD and there are also young patients, the disease has always been associated with elderly people. Sufferers also often have to contend with…
View Post 5 min This content is machine translated Syndromes of vertigo Not only the domain of physical therapy With a lifetime prevalence of up to 30%, dizziness is a very common leading symptom in consultations with a wide range of disciplines, from ENT specialists to general practitioners and…
View Post 8 min This content is machine translated Parkinson's disease Clear reduction of motor fluctuations due to opicapone Many Parkinson’s patients experience motor fluctuations after several years of therapy. The duration of these uncontrollable fluctuations in mobility can be significantly reduced by adjuvant therapy with the COMT inhibitor…
